US Patent Issued to Mablink Bioscience on Sept. 15 for "Antibody-drug conjugates and their uses" (French Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,244, issued on Sept. 15, was assigned to Mablink Bioscience (Lyons, France).

"Antibody-drug conjugates and their uses" was invented by Warren Viricel (Sainte Consorce, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibody-drug conjugates, wherein the antibody specifically binds to folate receptor a, and wherein the drug is preferably chosen among a cytotoxic drug. Such antibody-drug conjugates are useful in particular in treating proliferative diseases including cancers, such as ovarian, breast and non-small cell lung cancers."

The patent was filed on March 10, 2023, under Application No. 18/844,818.

*For...